日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Expression, purification, crystallization and X-ray data collection for RAS and its mutants

RAS及其突变体的表达、纯化、结晶和X射线数据收集

Johnson, Christian W; Buhrman, Greg; Ting, Pamela Y; Colicelli, John; Mattos, Carla

Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding

ABL 对 RAS 的酪氨酸磷酸化可增强效应物结合

Pamela Y Ting, Christian W Johnson, Cong Fang, Xiaoqing Cao, Thomas G Graeber, Carla Mattos, John Colicelli

Identification of small molecules that disrupt signaling between ABL and its positive regulator RIN1

鉴定破坏 ABL 与其正调节剂 RIN1 之间信号传导的小分子

Pamela Y Ting, Robert Damoiseaux, Björn Titz, Kenneth A Bradley, Thomas G Graeber, Virneliz Fernández-Vega, Thomas D Bannister, Peter Chase, Reji Nair, Louis Scampavia, Peter Hodder, Timothy P Spicer, John Colicelli

The RAB5-GEF function of RIN1 regulates multiple steps during Listeria monocytogenes infection

RIN1 的 RAB5-GEF 功能在单核细胞增生李斯特菌感染过程中调节多个步骤

Kavitha Balaji, Christopher T French, Jeff F Miller, John Colicelli

RIN1 regulates cell migration through RAB5 GTPases and ABL tyrosine kinases

RIN1 通过 RAB5 GTPases 和 ABL 酪氨酸激酶调节细胞迁移

Kavitha Balaji, John Colicelli

RIN1 orchestrates the activation of RAB5 GTPases and ABL tyrosine kinases to determine the fate of EGFR

RIN1 调控 RAB5 GTPases 和 ABL 酪氨酸激酶的激活,从而决定 EGFR 的命运

Kavitha Balaji, Chelsea Mooser, Christine M Janson, Joanne M Bliss, Houmehr Hojjat, John Colicelli

RIN3 is a negative regulator of mast cell responses to SCF

RIN3 是肥大细胞对 SCF 反应的负调节剂

Christine Janson, Noriyuki Kasahara, George C Prendergast, John Colicelli

ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1

ABL 融合致癌基因转化和抑制剂敏感性由细胞调节因子 RIN1 介导

M Thai, P Y Ting, J McLaughlin, D Cheng, M Müschen, O N Witte, J Colicelli

Signal transduction: RABGEF1 fingers RAS for ubiquitination

信号转导:RABGEF1 介导 RAS 泛素化

Colicelli, John

ABL tyrosine kinases: evolution of function, regulation, and specificity

ABL酪氨酸激酶:功能、调控和特异性的演变

Colicelli, John